MedTrace Logo

Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention

NCT05120869 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 178

Last updated 2025-09-04

No results posted yet for this study

Summary

Healthcare providers (HCP) serving the El Paso U.S.-Mexico Border Region will be recruited to compare educational and professional skills interventions focused on the human papillomavirus (HPV). Our hypothesis is that improving provider knowledge and communication strategies about HPV and its vaccine will reduce hesitancy and increase uptake and completion among the populations they serve.

Conditions

  • Health Personnel Attitude
  • Health Knowledge, Attitudes, Practice

Interventions

BEHAVIORAL

Tailored HPV Education and Professional Skills Intervention Group

The provider education and professional skills intervention will involve audio and visual content and will be delivered in the English language.

BEHAVIORAL

General HPV Education and Communication Skills Control Group

The general provider education intervention will involve audio and visual content and will be delivered in the English language.

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Burrell College of Osteopathic Medicine

    collaborator OTHER

  • University of Texas, El Paso

    lead OTHER

Principal Investigators

  • Eva M Moya, PhD, LMSW · The University of Texas at El Paso, Border Biomedical Research Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-22
Primary Completion
2024-12-02
Completion
2024-12-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05120869 on ClinicalTrials.gov